Are beauty and goodness the same? The relationship between beauty and goodness has long been a controversial issue in the fields of philosophy, aesthetics, ethics and psychology. Although many empirical studies have explored moral judgment and aesthetic judgment separately, only a few studies have compared the two. Whether these two judgments are two different processes or the same process with two different labels remains unclear. To answer this question, the present study directly compared the influence of facial attractiveness on judgments of moral goodness and moral beauty and revealed distinct contributions of imaging perceptions to these two judgments. The results showed that in the moral beauty judgment task, participants gave higher scores to characters with attractive faces compared with characters with unattractive faces, and larger P200 and LPP were elicited in the unattractive-face condition compared with the attractive-face condition; while in the moral goodness judgment task, there was no significant difference between the two conditions of either behaviour or ERP data. These findings offer important insights into the understanding and comparison of the processes of moral judgment and aesthetic judgment.
Creative insight has attracted much attention across cultures. Although previous studies have explored the neural correlates of creative insight by functional magnetic resonance imaging (fMRI), little is known about intrinsic resting-state brain activity associated with creative insight. In the present study, we used amplitude of low-frequency fluctuation (ALFF) as an index in resting-state fMRI (rs-fMRI) to identify brain regions involved in individual differences in creative insight, which was measured by the response time of creative Chinese character chunk decomposition. Our results showed that ALFF in the superior frontal gyrus (SFG) positively predicted creative insight, while ALFF in the middle cingulate cortex/insula cortex (MCC/IC), superior temporal gyrus/angular gyrus (STG/AG), anterior cingulate cortex/caudate nucleus (ACC/CN), and culmen/declive (CU/DC) negatively predicted creative insight. Moreover, these findings indicate that spontaneous brain activity in multiple regions related to breaking mental sets, solutions exploring, evaluation of novel solutions, forming task-related associations, and emotion experience contributes to creative insight. In conclusion, the present study provides new evidence to further understand the cognitive processing and neural correlates of creative insight.
Creative insight plays an important role in our daily life. Previous studies have investigated the neural correlates of creative insight by functional magnetic resonance imaging (fMRI), however, the intrinsic resting-state brain activity associated with creative insight is still unclear. In the present study, we used regional homogeneity (ReHo) as an index in resting-state fMRI (rs-fMRI) to identify brain regions involved in individual differences in creative insight, which was compued by the response time (RT) of creative Chinese character chunk decomposition. The findings indicated that ReHo in the anterior cingulate cortex (ACC)/caudate nucleus (CN) and angular gyrus (AG)/superior temporal gyrus (STG)/inferior parietal lobe (IPL) negatively predicted creative insight. Furthermore, these findings suggested that spontaneous brain activity in multiple regions related to breaking and establishing mental sets, goal-directed solutions exploring, shifting attention, forming new associations and emotion experience contributes to creative insight. In conclusion, the present study provides new evidence to further understand the cognitive processing and neural correlates of creative insight.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.